A NanoFCM comparison should start with a simple question: what level of information does the laboratory need to obtain from its biological nanoparticles? The NanoFCM NanoAnalyzer is associated with nano-flow cytometry, a technology designed to analyze individual particles by combining scattering and fluorescence.
To compare this platform with other instruments, it is necessary to distinguish between phenotyping, fast counting, concentration measurement, size distribution and subpopulation characterization needs. Depending on the application, NTA, TRPS, ILM or fluorescence-based viral counting technologies will not address the same constraints.
NanoFCM comparison : Understanding the NanoAnalyzer positioning
The NanoFCM NanoAnalyzer is presented as a nano-flow cytometry solution for multiparametric analysis of individual biological particles. This approach enables the study of complex samples such as extracellular vesicles, exosomes, viruses, lipid nanoparticles and bacteria.
Its value lies in the combination of side scatter and fluorescence. This combination makes it possible to go beyond size or concentration measurement and access information related to markers, subpopulations and biochemical properties of particles.
This level of detail explains why NanoFCM cannot be compared exactly with a simple particle counter. The platform is more relevant for laboratories looking to qualify individual biological particles than for those needing only rapid concentration control.
Identifying nano-flow cytometry constraints
Nano-flow cytometry provides a high level of information, but it also involves operational constraints. Sheath-flow operation requires rigorous preparation, dilution control and event rate monitoring.
Dilution is a critical point. If several particles pass through the detection area simultaneously, they may be interpreted as a single event. This phenomenon, known as swarm detection, can distort measurements when samples are too concentrated or too heterogeneous.
These constraints do not reduce the value of the technology. They simply show that a highly sensitive and highly informative instrument is not always the most suitable solution for routine analysis. For rapid screening, process monitoring or initial concentration estimation, a simpler approach can be relevant as a complement.
Comparing available technologies
| Platform | Principle | Available data | Main use |
| NanoAnalyzer – NanoFCM | Nano-flow cytometry | Size, concentration, biochemical properties, fluorescence | Biological particle phenotyping |
| NanoSight – Malvern Panalytical | NTA | Size, concentration, fluorescence depending on configuration | Nanoparticle analysis and population monitoring |
| ZetaView – Particle Metrix | NTA | Size, concentration, zeta potential, fluorescence | Multiparametric analysis and subpopulations |
| Exoid – Izon | TRPS | Size, concentration, charge | Single-particle analysis with access to charge |
| Virus Counter – Sartorius | Fluorescence-based counting | Specific viral counting | Targeted viral particle analysis |
| Videodrop – Myriade Lab | ILM | Size and concentration | Fast counting, low volume, process monitoring |
This table shows that no single technology can address every need. The choice depends on the priority parameter: fluorescence, charge, speed, resolution, low sample volume or biological specificity.
Choosing according to phenotyping needs
When the objective is to phenotype individual particles, NanoFCM keeps a specific positioning. The analysis is not only about counting particles or measuring their size. It also aims to obtain information about their identity, markers or biochemical properties.
This approach may be relevant for studying extracellular vesicles, exosomes or other biological nanoparticles with different subpopulations. In this context, fluorescence plays an important role because it links specific signals to individual particles.
An NTA platform equipped with fluorescence can address certain needs, particularly when observing a labeled population. However, it is not always positioned in the same way as a nano-flow cytometry solution designed for the phenotyping of individual biological particles.
Choosing according to fast counting needs
In other contexts, the laboratory does not need such detailed analysis. It mainly needs to rapidly obtain particle concentration and size distribution in order to monitor a process, compare batches or guide experimental decisions.
In this case, a faster and simpler technology may be useful. ILM-based instruments such as Videodrop can perform label-free counting using a low sample volume. This approach can be suitable for routine controls or repeated measurements.
The goal is not to replace phenotyping when it is required. It is rather to reserve the most complex methods for analyses that justify them, while using a more direct tool for routine size and concentration measurements.
Considering charge, fluorescence and critical size
The choice of technology also depends on the additional parameters required. If surface charge is essential, a TRPS platform or an NTA solution equipped for zeta potential may become a priority. If analysis depends on markers, fluorescence becomes a central criterion.
Particle size must also be considered. Some technologies are better suited to small particles, while others become relevant for more concentrated samples or rapid monitoring. Published limits should always be interpreted according to the real nature of the particles, because the optical properties of a biological particle may differ from those of a standard.
The laboratory must therefore start from its real samples: particle type, critical size, concentration, heterogeneity, labeling needs and analysis throughput.
Evaluating laboratory organization
An instrument should not be selected only for its technical performance. It must also fit the laboratory’s daily organization. Preparation time, cleaning, consumables, operator training and reproducibility between users can strongly affect the real value of a solution.
An expert platform may be ideal for occasional in-depth analysis, but become heavy to use if it has to process a large number of simple samples. Conversely, a fast counter can absorb part of the routine workflow and prepare more detailed analyses more efficiently.
This complementarity is often more realistic than a direct replacement. A laboratory can use a fast technology to select samples, adjust dilutions or monitor batches, then reserve a more complete platform for analyses requiring fluorescence, charge or phenotyping.
Comparing NanoFCM according to the data actually needed
A NanoFCM comparison should not aim to identify one universally better instrument. It should help determine which technology is most coherent according to the data required by the laboratory.
If the main objective is phenotyping individual biological particles, nano-flow cytometry remains highly relevant. If the need concerns fast counting, size, concentration or process monitoring, a complementary technology may be more suitable. If charge or multiparametric fluorescence is central, other platforms may also be included in the comparison.
A NanoFCM comparison should therefore be built around real use cases: sample type, critical size, expected information level, throughput, available volume and acceptable daily complexity.
